Talus Bio

Summer 2021Active

Discovering drugs that target the DNA regulome

Save

Talus Bio

Summer 2021Active

Discovering drugs that target the DNA regulome

Save

Company details

We have built a platform that enables drug discovery and development for previously undruggable genome regulators ("the regulome"). We accomplish this by moving drug discovery out of artificial systems where regulome proteins fail to function properly, and back into live human cells. Our technology combines innovations in automated cell processing, next-gen proteomics, and advanced data analytics to measure a drug's effect on the entire regulome in one experiment.

Location

Seattle, WA, USA

Founded

Unknown

Request the Talus Bio report.

Talus Bio has no report yet. Sign in with your email to request one.